Weight LossVery-low-calorie ketogenic diet

Clinical evidence dossier

Very-low-calorie ketogenic diet

Body weight

Evidence signal

Authoritative evidence signal

strong

This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.

Evidence snapshot

Authoritative support records
3
Supporting studies available for review
3
Randomized trials
1
Reported effects
5

Clinical conclusion

Very-low-calorie ketogenic diet shows a strong positive evidence signal for improving Body weight across the studied comparisons.

Observed effects

Observed study estimates; not a pooled treatment effect.

Change from baseline

Absolute change

-3.5 to -3.5 %

1 eligible estimates12–12 weeksObserved median: -3.5 %

Evidence composition

Non-randomized studies
0
Other designs
0
Unresolved designs
2
Magnitude-eligible effects
1

Consistency

Authoritative consistency classification

consistent

Positive
3
No effect
0
Mixed
0
Negative
0

Population and applicability

Structured population data were available for 3 of 3 supporting studies. 3 studies described participants with type 2 diabetes. 2 studies described adult participants.

This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.

View reported population descriptions

These descriptions are reported across the supporting studies; they are not a single synthesized population.

  • Obese individuals aged 18 and older.
  • Individuals diagnosed with prediabetes or early onset type 2 diabetes.
  • Adults with type 2 diabetes
  • Individuals seeking dietary interventions for metabolic control
  • Adults newly diagnosed with type 2 diabetes.
  • Patients seeking dietary interventions for diabetes management.

Limitations

  • 2 relevant studies have unresolved authoritative design evidence and do not contribute to design-specific or RoB-specific claims.
  • Evidence uses heterogeneous comparison contexts: baseline_within_group, usual_care.
  • 2 supporting studies have high, serious, critical, unclear, or unavailable risk-of-bias information.
  • 2 of 3 studies with duration data have follow-up of 12 weeks or less.

Supporting evidence

Inspect the authoritative studies and omitted support records for this dossier.

View supporting evidence